von Willebrand Disease

Von Willebrand disease is the most common inherited bleeding disorder. It is caused by a quantitative deficiency or qualitative defect of von Willebrand factor, a large plasma protein that mediates platelet adhesion and carries and protects factor VIII. Because von Willebrand factor sits at the interface of primary and secondary hemostasis, its dysfunction typically produces mucocutaneous bleeding such as nosebleeds, easy bruising, and heavy menstrual bleeding.

Definition

Von Willebrand disease is an inherited bleeding disorder resulting from a reduced quantity (types 1 and 3) or impaired function (type 2) of von Willebrand factor, leading to defective platelet adhesion and, because the factor stabilizes factor VIII, sometimes a secondary reduction in factor VIII activity.

Scope

This entry covers the dual role of von Willebrand factor, the major disease types reflecting partial deficiency, qualitative defects, and near-complete absence, the resulting bleeding pattern, and the conceptual basis of diagnosis. It treats von Willebrand disease as a reference topic and does not provide individualized diagnostic thresholds or treatment guidance.

Core questions

• How does von Willebrand factor link platelet adhesion with the protection of factor VIII?
• How do the disease types distinguish quantitative deficiency from qualitative dysfunction?
• Why does von Willebrand disease cause mucocutaneous rather than deep-tissue bleeding?

Key concepts

• Von Willebrand factor structure and multimers
• Platelet adhesion to subendothelium
• Factor VIII carrier function
• Type 1 (partial quantitative deficiency)
• Type 2 (qualitative defects)
• Type 3 (near-complete deficiency)
• Mucocutaneous bleeding pattern

Mechanisms

Von Willebrand factor is a large multimeric glycoprotein with two complementary roles. At sites of vascular injury its high-molecular-weight multimers bind exposed collagen and tether platelets through their glycoprotein Ib receptor, initiating platelet adhesion under shear. In the circulation it also binds and stabilizes factor VIII, prolonging the factor's half-life. When von Willebrand factor is reduced (type 1), structurally abnormal (type 2), or virtually absent (type 3), platelet adhesion is impaired and factor VIII levels may fall secondarily, producing a bleeding tendency that combines a primary hemostatic defect with a variable coagulation defect. Leebeek and Eikenboom (2016) review this pathophysiology and its classification.

Clinical relevance

Recognizing von Willebrand factor's dual role explains why von Willebrand disease can prolong tests of both platelet function and, when factor VIII is low, the activated partial thromboplastin time, and why bleeding is characteristically mucocutaneous. This entry is a reference description; diagnostic confirmation and management follow specialist guidelines and are outside its scope.

Epidemiology

Von Willebrand disease is the most common inherited bleeding disorder, with type 1 accounting for the majority of cases and the severe type 3 being rare. Symptomatic disease is less frequent than laboratory abnormalities, and heavy menstrual bleeding is a common presentation in affected women. Prevalence estimates are discussed in Leebeek and Eikenboom (2016) and the ASH/ISTH diagnostic guidelines (James et al., 2021).

Evidence & guidelines

The ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease (James et al., 2021) provide the principal current framework for classification and diagnostic testing. This entry references that guideline for orientation rather than reproducing its specific recommendations.

History

The disorder was first described in 1926 by the Finnish physician Erik von Willebrand, who reported a hereditary bleeding tendency among families on the Åland Islands that differed from hemophilia. The responsible protein, von Willebrand factor, was later characterized as a distinct adhesive glycoprotein separate from factor VIII, and molecular studies clarified the basis of the quantitative and qualitative disease types that define the modern classification.

Key figures

• Erik von Willebrand
• Frits Leebeek
• Jeroen Eikenboom
• Paula James

Seminal works

• leebeek-eikenboom-2016
• james-2021

Frequently asked questions

Why is von Willebrand disease called the most common bleeding disorder?

It is the most frequently inherited bleeding disorder because variants reducing or altering von Willebrand factor are relatively common in the population, although many affected people have mild or only laboratory-detectable disease.

How does von Willebrand disease differ from hemophilia?

Hemophilia results from a deficiency of factor VIII or IX and typically causes deep joint and muscle bleeding, while von Willebrand disease results from deficient or dysfunctional von Willebrand factor and causes mainly mucocutaneous bleeding, though low factor VIII can occur secondarily.